Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 7 (2010), Issue 6 (June)

1. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
   J Rheumatol, 37(6): 1136-42. [Abstract] [Full-text]
2. Androgens and integrins in salivary glands in Sjogren's syndrome.
   J Rheumatol, 37(6): 1181-7. [Abstract] [Full-text]
3. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides.
   J Rheumatol, 37(6): 1113-20. [Abstract] [Full-text]
4. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis.
   J Rheumatol, 37(6): 1121-8. [Abstract] [Full-text]
5. Golimumab for rheumatoid arthritis: a systematic review.
   J Rheumatol, 37(6): 1096-104. [Abstract] [Full-text]
6. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
   J Rheumatol, 37(6): 1105-12. [Abstract] [Full-text]
7. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset.
   J Rheumatol, 37(6): 1143-9. [Abstract] [Full-text]
8. Comorbidities in patients with primary Sjogren's syndrome: a registry-based case-control study.
   J Rheumatol, 37(6): 1188-94. [Abstract] [Full-text]
9. Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells.
   J Immunol, 184(12): 7297-304. [Abstract] [Full-text]
10. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.
    J Immunol, 184(12): 6882-90. [Abstract] [Full-text]
11. Regulatory T cells protect from local and systemic bone destruction in arthritis.
    J Immunol, 184(12): 7238-46. [Abstract] [Full-text]
12. Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3.
    J Immunol, 184(12): 7162-8. [Abstract] [Full-text]
13. Viruses and arthritis: new challenges in diagnosis, therapy, and immunization.
    Am J Med Sci, 339(6): 549-56. [Abstract] [Full-text]
14. Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: a dissemination and implementation study.
    Arthritis Care Res (Hoboken), 62(6): 865-72. [Abstract] [Full-text]
15. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.
    Arthritis Care Res (Hoboken), 62(6): 857-64. [Abstract] [Full-text]
16. Disease severity and domain-specific arthritis self-efficacy: relationships to pain and functioning in patients with rheumatoid arthritis.
    Arthritis Care Res (Hoboken), 62(6): 848-56. [Abstract] [Full-text]
17. Factors that influence rheumatologists' decisions to escalate care in rheumatoid arthritis: results from a choice-based conjoint analysis.
    Arthritis Care Res (Hoboken), 62(6): 842-7. [Abstract] [Full-text]
18. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Care Res (Hoboken), 62(6): 775-84. [Abstract] [Full-text]
19. Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
    Arthritis Care Res (Hoboken), 62(6): 755-63. [Abstract] [Full-text]
20. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines.
    Arthritis Care Res (Hoboken), 62(6): 791-9. [Abstract] [Full-text]
21. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Arthritis Care Res (Hoboken), 62(6): 821-5. [Abstract] [Full-text]
22. Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis.
    Clin Chim Acta, 411(15): 1046-50. [Abstract] [Full-text]
23. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis.
    Arthritis Rheum, 62(6): 1813-23. [Abstract] [Full-text]
24. Adiponectin stimulates prostaglandin E(2) production in rheumatoid arthritis synovial fibroblasts.
    Arthritis Rheum, 62(6): 1641-9. [Abstract] [Full-text]
25. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Arthritis Rheum, 62(6): 1683-92. [Abstract] [Full-text]
26. The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation.
    Arthritis Rheum, 62(6): 1660-5. [Abstract] [Full-text]
27. Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects.
    Arthritis Rheum, 62(6): 1781-91. [Abstract] [Full-text]
28. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.
    Arthritis Rheum, 62(6): 1792-802. [Abstract] [Full-text]
29. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
    Arthritis Rheum, 62(6): 1803-12. [Abstract] [Full-text]
30. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.
    Arthritis Rheum, 62(6): 1576-82. [Abstract] [Full-text]
31. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
    Arthritis Rheum, 62(6): 1620-9. [Abstract] [Full-text]
32. Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood.
    Arthritis Rheum, 62(6): 1602-7. [Abstract] [Full-text]
33. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis.
    Arthritis Rheum, 62(6): 1824-8. [Abstract] [Full-text]
34. Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.
    Arthritis Rheum, 62(6): 1608-19. [Abstract] [Full-text]
35. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
    Arthritis Rheum, 62(6): 1583-91. [Abstract] [Full-text]
36. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.
    Clin Exp Immunol, 160(3): 340-7. [Abstract] [Full-text]
37. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.
    Clin Exp Immunol, 160(3): 305-17. [Abstract] [Full-text]
38. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
    Immunology, 130(2): 296-306. [Abstract] [Full-text]
39. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis.
    Ann Rheum Dis, 69(7): 1275-80. [Abstract] [Full-text]
40. Juvenile idiopathic arthritis: state of the art and future perspectives.
    Ann Rheum Dis, 69(7): 1260-3. [Abstract] [Full-text]
41. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.
    Ann Rheum Dis, 69(7): 1333-7. [Abstract] [Full-text]
42. Salivary gland ultrasonography: can it be an alternative to sialography as an imaging modality for Sjogren's syndrome?
    Ann Rheum Dis, 69(7): 1321-4. [Abstract] [Full-text]
43. A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment.
    Ann Rheum Dis, 69(7): 1349-51. [Abstract] [Full-text]
44. Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial.
    Ann Rheum Dis, 69(7): 1342-5. [Abstract] [Full-text]
45. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Ann Rheum Dis, 69(7): 1352-5. [Abstract] [Full-text]
46. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Ann Rheum Dis, 69(7): 1315-20. [Abstract] [Full-text]
47. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis.
    Ann Rheum Dis, 69(7): 1292-7. [Abstract] [Full-text]
48. Synovial tissue hypoxia and inflammation in vivo.
    Ann Rheum Dis, 69(7): 1389-95. [Abstract] [Full-text]
49. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission.
    Ann Rheum Dis, 69(7): 1298-304. [Abstract] [Full-text]
50. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.
    Ann Rheum Dis, 69(7): 1286-91. [Abstract] [Full-text]
51. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Ann Rheum Dis, 69(7): 1281-5. [Abstract] [Full-text]
52. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    Ann Rheum Dis, 69(7): 1378-82. [Abstract] [Full-text]
53. Total cholesterol and LDL levels decrease before rheumatoid arthritis.
    Ann Rheum Dis, 69(7): 1310-4. [Abstract] [Full-text]
54. CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis.
    Clin Immunol, 136(1): 139-47. [Abstract] [Full-text]
55. The role of microRNA in rheumatoid arthritis and other autoimmune diseases.
    Clin Immunol, 136(1): 1-15. [Abstract] [Full-text]
56. Temporomandibular joint findings in adults with long-standing juvenile idiopathic arthritis: CT and MR imaging assessment.
    Radiology, 256(1): 191-200. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.